arrow
R

Russell Petty

university of dundee
H指数:26
被引数:3,624

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Maintenance capecitabine after first-line platinum-based chemotherapy in advanced oesophagogastric adenocarcinoma: final analysis from the PLATFORM trial

晚期食管胃腺癌一线铂类化疗后卡培他滨维持治疗:PLATFORM试验的最终分析

2026-04-210
OAAI
Correction: Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma

更正:相对端粒长度和衰老相关炎性细胞因子作为晚期或可切除胃食管腺癌患者血液基质的预后标志物

2025-12-190
OAAI
Immune cell senescence drives responsiveness to immunotherapy in melanoma

免疫细胞衰老驱动黑色素瘤对免疫治疗的应答

2025-12-100
OA
Relative telomere length and senescence-associated inflammatory cytokines as blood-based prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma

相对端粒长度和衰老相关炎性细胞因子作为血液基 prognostic markers in patients with advanced or resectable gastro-oesophageal adenocarcinoma

2025-11-170
OAAI
AKT/mTOR as a targetable hub to overcome multimodal resistance to EGFR inhibitors in oesophageal squamous cell carcinoma

AKT/mTOR作为克服食管鳞状细胞癌对EGFR抑制剂的多模态耐药性的可靶向枢纽

2025-07-040
OAAI
Generation of a selective senolytic platform using a micelle-encapsulated Sudan Black B conjugated analog (vol 5, pg 162, 2025)

使用一种包封于胶束中的苏丹黑B偶联类似物构建选择性细胞凋亡平台(卷5,页162,2025)

2025-01-311
OA
Generation of a selective senolytic platform using a micelle-encapsulated Sudan Black B conjugated analog

利用微球包封的苏丹黑B偶联类似物构建选择性 senolytic 平台

2024-12-274
OA
Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial
2024-11-010
PRE
Loss of the tumour suppressor LKB1/STK11 uncovers a leptin-mediated sensitivity mechanism to mitochondrial uncouplers for targeted cancer therapy

肿瘤抑制因子LKB1/STK11的缺失揭示了瘦素介导的对线粒体解偶联剂的敏感性机制,用于靶向癌症治疗

2024-07-252
OAAI
Maintenance durvalumab after fi rst-line chemotherapy in patients with HER2-negative advanced oesophago-gastric adenocarcinoma: results from the randomised PLATFORM study
2024-07-010
OAAI
An investigation of the clinical impact and therapeutic relevance of a DNA damage immune response (DDIR) signature in patients with advanced gastroesophageal adenocarcinoma
2024-05-011
OAAI
A decade of the Oesophageal Cancer Clinical and Molecular Stratification Consortium

食道癌临床和分子分层联盟的十年

2023-12-190
PRE
A fluorophore-conjugated reagent enabling rapid detection, isolation and live tracking of senescent cells
2023-10-0111
OA